Related Experiment Video
Updated: May 6, 2026

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol esters: synthesis, anti-Candida potential and molecular modeling studies
Mohamed I Attia1, Awwad A Radwan, Azza S Zakaria
1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P,O, Box 2457, Riyadh 11451, Saudi Arabia. mattia@ksu.edu.sa.
Background:
An increased incidence of fungal infections, both invasive and superficial, has been witnessed over the last two decades. Candida species seem to be the main etiology of nosocomial fungal infections worldwide with Candida albicans, which is commensal in healthy individuals, accounting for the majority of invasive Candida infections with about 30-40% of mortality.
Results:
New aromatic and heterocyclic esters 5a-k of 1-aryl-3-(1H-imidazol-1-yl)propan-1-ols 4a-d were successfully synthesized and evaluated for their anti-Candida potential. Compound 5a emerged as the most active congener among the newly synthesized compounds 5a-k with MIC value of 0.0833 μmol/mL as compared with fluconazole (MIC value >1.6325 μmol/mL). Additionally, molecular modeling studies were conducted on a set of anti-Candida albicans compounds.
Conclusion:
The newly synthesized esters 5a-k showed more potent anti-Candida activities than fluconazole. Compounds 7 and 8 revealed significant anti-Candida albicans activity and were able to effectively satisfy the proposed pharmacophore geometry, using the energy accessible conformers (Econf < 20 kcal/mol).
Insights
New esters demonstrate potent anti-Candida activity, outperforming fluconazole. Compound 5a showed significant efficacy against Candida infections, offering a promising alternative for treating fungal diseases.
Area of Science:
- Medicinal Chemistry
- Antimicrobial Drug Discovery
Background:
- Rising incidence of invasive and superficial fungal infections globally.
- Candida species are a major cause of hospital-acquired fungal infections.
- Candida albicans causes most invasive Candida infections, with high mortality rates.
Purpose of the Study:
- Synthesize novel aromatic and heterocyclic esters.
- Evaluate the anti-Candida potential of synthesized compounds.
- Investigate compounds for activity against Candida albicans.
Main Methods:
- Synthesis of 1-aryl-3-(1H-imidazol-1-yl)propan-1-ol esters (5a-k).
- Antifungal activity evaluation using Minimum Inhibitory Concentration (MIC) assays.
- Molecular modeling studies to assess pharmacophore geometry.
Main Results:
- Compound 5a exhibited potent anti-Candida activity with an MIC of 0.0833 μmol/mL.
- The synthesized esters (5a-k) showed superior activity compared to fluconazole.
- Compounds 7 and 8 demonstrated significant anti-Candida albicans activity.
Conclusions:
- Newly synthesized esters possess potent anti-Candida activity.
- Compounds 7 and 8 effectively match proposed pharmacophore models.
- These novel esters represent promising candidates for antifungal drug development.
Related Concept Videos
Antifungal Agents
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
